Insiders BerGenBio ASA

Equities

BGBIO

NO0010650013

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-08 EDT			5-day change	1st Jan Change
0.137 ^NOK	0.00%		-5.52%	-50.72%

03-20	Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation	CI
02-14	BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virax Biolabs Group Names Nigel McCracken Operating Chief.	23-09-01	MT
BerGenBio ASA Announces Resignation of Francois Thomas from the Board of Directors	23-05-22	CI
BerGenBio ASA Announces Board Appointments	23-02-02	CI
Norway's BerGenBio Names Chief Medical Officer	22-04-11	MT
BerGenBio ASA Appoints Cristina Oliva as Chief Medical Officer, Effective April 25, 2022	22-04-11	CI
BerGenBio Names Former Bristol-Myers Squibb Executive As New Chair	22-01-06	MT
BerGenBio ASA Announces Change of Chairman of Board	22-01-06	CI
BerGenBio : Appoints AcouSort Chairman As CEO	21-08-24	MT
BerGenBio ASA Announces Management Changes	21-08-23	CI
Bergenbio : CEO Steps Down, Successor Named	21-08-23	MT
Bergenbio Announces Executive Changes	21-08-06	CI
BerGenBio ASA Elects Hans Peter Bohn as Member to the Board of Directors	19-03-13	CI
Stein Holst Annexstad´s Expresses Not to Seek Re-Election as Chairman of BerGenBio ASA	19-02-20	CI
BerGenBio ASA Announces Executive Changes	18-11-21	CI
BerGenBio ASA Appoints Rune Skeie as Chief Financial Officer	18-03-05	CI
BerGenBio AS Appoints Non-Executive Directors	15-09-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW